InvestorsHub Logo
Followers 12
Posts 1261
Boards Moderated 0
Alias Born 04/12/2011

Re: None

Thursday, 06/01/2017 3:30:37 PM

Thursday, June 01, 2017 3:30:37 PM

Post# of 487
7:47 am ET
*Ionis Pharma Reports Earning of $50M Milestone Payment from Biogen Following EC Marketing Authorization for SPINRAZA
Benzinga
7:30 am ET
SPINRAZA(R) (Nusinersen) Approved in the European Union as First Treatment for Spinal Muscular Atrophy
BusinessWire

I don't understand why we are only up 6%?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IONS News